At the Annual Meeting of the Company held on April 25, 2019, the following proposals were voted on by the Company\’s stockholders, as set forth below:

Proposal 1: Election of Directors

The foregoing candidates were elected to the Companys board of directors.

Proposal 2: Advisory Vote on Executive Compensation

The executive compensation program for the Companys named executive officers was approved on an advisory basis.

Proposal 3: Approval of the Aemetis, Inc. 2019 Stock Plan

The Companys 2019 Stock Plan was approved.

Proposal 4: Ratification of Auditors

The appointment of RSM US LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2019 was approved.

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standards; Transfer of Listing.

On April 24, 2019, Aemetis, Inc. (the Company) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (Nasdaq) indicating that, based upon the most recent publicly held shares information and the closing bid price of the Companys common stock for the last 30 consecutive business days, the Company did not meet the minimum market value of publicly held shares (MVPHS) of $15,000,000 required for continued listing on The Nasdaq Global Market to Nasdaq Listing Rule 5450(b)(3)(C). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until October 21, 2019, in which to regain compliance to Nasdaq Listing Rule 5810(c)(3)(D). The letter further provided that if, at any time during the 180 calendar day period, the Companys MVPHS closes at $15,000,000 or more for a minimum of ten consecutive business days, Nasdaq will provide the Company with written confirmation of compliance that it has achieved compliance with the MVPHS requirement. If the Company does not regain compliance by October 21, 2019, it will receive written notification that the Companys common stock is subject to delisting. At that time, the Company may appeal the delisting determination to a Hearings Panel, which may provide an exception for the Company to regain compliance with the MVPHS requirement.

The Company intends to actively monitor the MVPHS for its common stock between now and October 21, 2019, and intends to take any reasonable actions to resolve the Companys noncompliance with the MVPHS requirement, respectively, as may be necessary. No determination regarding the Companys response has been made at this time. There can be no assurance that the Company will be able to regain compliance with the MVPHS requirement, or will otherwise be in compliance with other Nasdaq listing criteria.

About AEMETIS, INC. (NASDAQ:AMTX)

Aemetis, Inc. is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries. Its segments include North America and India. The North America segment includes the Company’s approximately 60 million gallon per year capacity ethanol manufacturing plant in Keyes, California and its technology lab in College Park, Maryland. The India segment includes the Company’s over 50 million gallon per year capacity biodiesel manufacturing plant in Kakinada, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Keyes plant produces denatured ethanol, Wet Distillers Grains, corn oil and Condensed Distillers Solubles. It produces biodiesel and refined glycerin at the Kakinada plant.